Latest Anti-hypertensives News
TIPS-3 Trial: The Combination of Polypill and Aspirin Administered to Patients at Intermediate Risk Led to a Lower Incidence of Cardiovascular Events Compared With Double Placebo
A recent trial by Dr. Salim Yusuf, published in The New England Journal…
REPLACE COVID Trial: Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Can Be Safely Continued in Patients Admitted to Hospital With COVID-19
A recent trial by Dr. Jordana B Cohen, published in The LANCET, indicated that…
A Population-Based Study Showed No Association Between COVID-19-Induced In-Hospital Death and Angiotensin-Converting–Enzyme Inhibitors and Angiotensin-Receptor Blockers Use
A recent study by Dr. Mehra, published in the New England Journal…
Population-Based Cohort Study Shows Blood Pressure Trajectories Over The Life Course Progress More Rapidly in Women Compared to Men
A new study by Dr. Hongwei, published in JAMA Cardiology, demonstrated that…
20,000 Patient Randomized Trial Shows Ingestion of Anti-hypertensive Medication at Night Associated with Better Blood Pressure Control and Improved Cardiovascular Outcomes
A randomized trial, led by Dr. Ramon Hermida, revealed that the routine…
CREOLE: Amlodipine with Either Perindopril or Hydrochlorothiazide Is Better Than Perindopril and Hydrochlorothiazide in Reducing Blood Pressure In Black Patients in Sub-Saharan Africa
A trial led by Dr. Dike Ojji published in the New England…
U.S. Food and Drug Administration (FDA) Continues To Investigate Recall of Contaminated Blood Pressure Medication
The US food and drug Administration (FDA) has recently been conducting an…